InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: DragonBear post# 76081

Sunday, 10/08/2017 4:24:40 PM

Sunday, October 08, 2017 4:24:40 PM

Post# of 144814
Wrong! You can't show not one single targeted therapy having superior intellectual property to CiaB.

Janssen, nor anyone else for that matter would be interested in PharmaCyte's CiaB therapy if that was true.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News